Article information
Abstract
Background
The monitoring of the underlying causes of death in people living with HIV/AIDS is important so that actions to reduce morbidity and mortality can be taken.
ObjectiveTo describe the temporal trends of underlying causes of death among people living with HIV/AIDS between 2000 and 2007 in Brazil and to identify factors associated with it.
MethodsThe Mortality Information System data for deaths occurred in Brazil between 2000 and 2007 that contained reference to HIV/AIDS in any of the death certificate fields was analyzed. Temporal trends of the underlying cause of death were studied. Differences in the underlying cause of death according to gender, age, region of residence, level of education, certifying officer, race and year of death were verified.
ResultsBetween 2000 and 2007 the percentage of deaths not related to HIV/AIDS among people living with HIV/AIDS increased from 2.5% to 7.0%. People with higher level of formal education, living in the South-East region of Brazil and aged under 13 or over 60 years old were more likely to have their underlying cause of death reported as not related to HIV/AIDS.
ConclusionThe results suggest the importance of implementing actions aimed at improving the quality of life of PLWHA, and which could include behavioral changes, such as smoking and alcoholism cessation, early screening to detect neoplasms and the monitoring of chronic conditions, such as diabetes. That is to say, the need exists to integrate the actions of HIV/AIDS programs with other public health programs.
Keywords:
AIDS
causes of death
HIV
Full text is only aviable in PDF
References
[1.]
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008.http://www.aids.gov.br/data/documents/storedDocuments/{B8EF5DAF-23AE-4891-AD36-1903553A3174}/{31A56BC6-307D-4C88-922D-6F52338D0-BF4}/Boletim2008_versão1_6.pdf. Access: 03/20/2009.
[2.]
Organização Mundial de Saúde. CID-10: Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde – Décima revisão. 2008. Volume 1. Available at: http://www.datasus.gov.br/cid10/v2008/cid10.htm.
[3.]
Pinheiro CE, Santo AH. Processamento de causas de morte em lote pelo sistema de seleção de causa básica. Rev. Saúde Pública 1998; 32(1):72–3. Available at: http://www.scielosp.org/scielo.php?script=sci_arttextπd=S0034-89101998000100010. Accessed on 05/27/2009.
[4.]
Matida LH, Ramos Jr NA, Moncau JEC et al. AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil. Cad Saúde Pública (FIOCRUZ) 2007; 23(S3):435–44. http://www.scielo.br/pdf/csp/v23s3/11.pdf. Accessed: 03/20/2009.
[5.]
Matida LH, Ramos Jr AN, Marques HHS et al. Ampliação da sobrevivência de crianças com aids: uma resposta brasileira sustentável. In: Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008. http://www.aids.gov.br/data/documents/storedDocuments/{B8EF5DAF-23AE-4891-AD36-1903553A3174}/{31A56BC6-307D-4C88-922D-6F52338D0-BF4}/Boletim2008_versão1_6.pdf. Accessed: 03/20/2009.
[6.]
J.R. Marins, L.F. Jamal, S.Y. Chen, et al.
Dramatic improvement in survival among adult Brazilian AIDS patients.
Aids, 17 (2003), pp. 1675-1682
[7.]
Guibu IA, Barros MBA, Cordeiro MRD et al. Estudo de Sobrevida de Pacientes de AIDS no Brasil, 1998 a 1999 – Fase I - Regiões Sul e Sudeste. In: Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. Boletim Epidemiológico AIDS DST, ano V, no 1, 2008. http://www.aids.gov.br/data/documents/storedDocuments/{B8EF5DAF-23AE-4891-AD36-1903553A3174}/{31A56BC6-307D-4C88-922D-6F52338D0-BF4}/Boletim2008_versão1_6.pdf. Access: 03/20/2009.
[8.]
SPSS [computer program]. Version 13.0 for windows. Release 13.0 (1 Sep 2004). Copyright © SPSS Inc., 1989–2004. All rights reserved. Network license user: Ministério da Saúde.
[9.]
H.B. Krentz, G. Kliewer, M.J. Gill.
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
HIV Med., 6 (2005), pp. 99-106
[10.]
B. Lau, S.J. Gange, R.D. Moore.
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 Cells/mm3.
J Acquir Immune Defic Syndr, 44 (2007), pp. 179-187
[11.]
J.E. Sackoff, D.B. Hanna, M.R. Pfeiffer, L.V. Toryan.
Ann Intern Med, (2006),
[12.]
N.F. Crum, R.H. Riffenburgh, S. Wegner, et al.
Comparisons of causes of death and mortality rates among HIV infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
J Acquir Immune Defic Syndr, 41 (2006), pp. 194-200
[13.]
A.G. Pacheco, S.H. Tuboi, J.C. Faulhaber, L.H. Harrison, M. Schechter.
Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil.
PLoS ONE, 3 (2008), pp. e1531
[14.]
M.K. Jain, D.J. Skiest, J.W. Cloud, et al.
Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999–2000.
Clin Infect Dis, 36 (2003), pp. 1030-1038
[15.]
E. Martınez, A. Milinkovic, E. Buira, et al.
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
HIV Med, 8 (2007), pp. 251-258
[16.]
F.J. Palella Jr., R.K. Baker, A.C. Moorman, HIV Outpatient Study Investigators, et al.
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
J Acquir Immune Defic Syndr, 43 (2006), pp. 27-34
[17.]
C.H. Yang, Y.F. Huang, C.F. Hsiao, et al.
Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984–2005.
British HIV Association HIV Medicine, 9 (2008), pp. 535-543
[18.]
A.G. Pacheco, S.H. Tuboi, S.B. May, et al.
Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil.
J Acquir Immune Defic Syndr, 51 (2009), pp. 624-630
[19.]
C. Lewden, M. Thierry, E. Rosenthal, et al.
Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalite 2000 and 2005” Surveys (ANRS EN19 and Mortavic).
JAIDS, 48 (2008), pp. 590-598
[20.]
J.E. Justman, L. Benning, A. Danoff, et al.
Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.
J Acquir Immune Defic Syndr, 32 (2003), pp. 298-302
[21.]
L.L. Dever, P.A. Onwari, W.E. Figueroa, C.A. O’Donovan, R.H. Eng.
Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority based population.
Ann Pharmacother, 34 (2000), pp. 580-584
[22.]
A. Carr, K. Samaras, A. Thorisdottir, et al.
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and DM: a cohort study.
Lancet, 353 (1999), pp. 2093-2099
[23.]
M.P. Dube, H. Edmondson-Melancon, D. Qian, et al.
Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients.
J Acquir Immune Defic Syndr, 27 (2001), pp. 130-134
[24.]
M.D. Stein, L. Hanna, R. Natarajan, et al.
Alcohol use patterns predict high-risk HIV behaviors among active injection drug users.
Journal of Substance Abuse Treatment, 18 (2000), pp. 359-363
[25.]
M. Windle.
The trading of sex for money or drugs, sexually transmitted diseases (STDs), and HIV-related risk behaviors among multisubstance using alcoholic inpatients.
Drug and Alcohol Dependence, 49 (1997), pp. 33-38
[26.]
A.L. Avins, W.J. Woods, C.P. Lindan, et al.
HIV infection and risk behaviors among heterosexuals in alcohol treatment programs.
JAMA, 271 (1994), pp. 515-518
[27.]
J.A. Boscarino, A.L. Avins, W.J. Woods, et al.
Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: Implications for prevention.
Journal of Studies on Alcohol, 6 (1995), pp. 642-653
[28.]
R.M. Malow, J.G. Dévieux, T. Jennings, B.A. Lucenko, S.C. Kalichman.
Substance-abusing adolescents at varying levels of HIV risk: Psychosocial characteristics, drug use, and sexual behavior.
J Subst Abuse, 13 (2001), pp. 103-117
[29.]
R. Weber, C.A. Sabin, N. Friis-Møller, et al.
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
Arch Intern Med, 166 (2006), pp. 1632-1641
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
